{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T22:42:20Z","timestamp":1773096140775,"version":"3.50.1"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81770491"],"award-info":[{"award-number":["81770491"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Ministry of Education Innovation Team Development Program of China","award":["IRT16R57"],"award-info":[{"award-number":["IRT16R57"]}]},{"DOI":"10.13039\/501100002412","name":"Young Talent Recruiting Plans of Xi\u2019an Jiaotong University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002412","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.cyto.2018.08.032","type":"journal-article","created":{"date-parts":[[2018,9,6]],"date-time":"2018-09-06T07:03:07Z","timestamp":1536217387000},"page":"237-245","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Natural killer T cell ligand alpha-galactosylceramide protects against gut ischemia reperfusion-induced organ injury in mice"],"prefix":"10.1016","volume":"111","author":[{"given":"Jia","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianbin","family":"Bi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yifan","family":"Ren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhaoqing","family":"Du","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teng","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingshan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengyun","family":"Ke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Lv","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0993-4531","authenticated-orcid":false,"given":"Rongqian","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1 Suppl","key":"10.1016\/j.cyto.2018.08.032_b0005","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.1136\/gut.35.1_Suppl.S73","article-title":"Gut ischaemia","volume":"35","author":"Haglund","year":"1994","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.cyto.2018.08.032_b0010","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s11938-001-0046-y","article-title":"Small Bowel Ischemia","volume":"4","author":"Nehme","year":"2001","journal-title":"Curr. Treat Options Gastroenterol."},{"issue":"3","key":"10.1016\/j.cyto.2018.08.032_b0015","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/MOT.0000000000000190","article-title":"Current knowledge on regulation and impairment of motility after intestinal transplantation","volume":"20","author":"von Websky","year":"2015","journal-title":"Curr. Opin. Organ. Transplant"},{"issue":"10","key":"10.1016\/j.cyto.2018.08.032_b0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2009.05.026","article-title":"Epidemiology, clinical features, high-risk factors, and outcome of acute large bowel ischemia","volume":"7","author":"Longstreth","year":"2009","journal-title":"Clin. Gastroenterol. Hepatol"},{"issue":"2","key":"10.1016\/j.cyto.2018.08.032_b0025","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s00423-007-0263-5","article-title":"Unchanged high mortality rates from acute occlusive intestinal ischemia: six year review","volume":"393","author":"Kassahun","year":"2008","journal-title":"Langenbecks Arch. Surg."},{"issue":"4","key":"10.1016\/j.cyto.2018.08.032_b0030","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.surg.2011.07.079","article-title":"Morbidity and mortality after bowel resection for acute mesenteric ischemia","volume":"150","author":"Gupta","year":"2011","journal-title":"Surgery"},{"issue":"9","key":"10.1016\/j.cyto.2018.08.032_b0035","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1023\/B:DDAS.0000042232.98927.91","article-title":"Ischemia-reperfusion injury of the intestine and protective strategies against injury","volume":"49","author":"Mallick","year":"2004","journal-title":"Dig. Dis. Sci."},{"issue":"10","key":"10.1016\/j.cyto.2018.08.032_b0040","doi-asserted-by":"crossref","first-page":"325","DOI":"10.4330\/wjc.v2.i10.325","article-title":"Ischemia\/reperfusion injury: The role of immune cells","volume":"2","author":"Zuidema","year":"2010","journal-title":"World J. Cardiol."},{"issue":"12","key":"10.1016\/j.cyto.2018.08.032_b0045","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1097\/TP.0000000000001411","article-title":"Innate immune regulations and liver ischemia-reperfusion injury","volume":"100","author":"Lu","year":"2016","journal-title":"Transplantation"},{"key":"10.1016\/j.cyto.2018.08.032_b0050","doi-asserted-by":"crossref","first-page":"6305439","DOI":"10.1155\/2017\/6305439","article-title":"Innate immune response in kidney ischemia\/reperfusion injury: potential target for therapy","volume":"2017","author":"Kezic","year":"2017","journal-title":"J. Immunol. Res."},{"issue":"5","key":"10.1016\/j.cyto.2018.08.032_b0055","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1158\/2326-6066.CIR-15-0062","article-title":"The regulatory role of invariant NKT cells in tumor immunity","volume":"3","author":"McEwen-Smith","year":"2015","journal-title":"Cancer Immunol. Res."},{"issue":"2","key":"10.1016\/j.cyto.2018.08.032_b0060","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.clim.2011.04.015","article-title":"NKT-cell-based immunotherapies in clinical trials","volume":"140","author":"Exley","year":"2011","journal-title":"Clin. Immunol."},{"issue":"12","key":"10.1016\/j.cyto.2018.08.032_b0065","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1038\/ni1203-1164","article-title":"The NKT cell system: bridging innate and acquired immunity","volume":"4","author":"Taniguchi","year":"2003","journal-title":"Nat. Immunol."},{"issue":"2","key":"10.1016\/j.cyto.2018.08.032_b0070","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.it.2012.08.009","article-title":"Invariant natural killer T cells as sensors and managers of inflammation","volume":"34","author":"Van Kaer","year":"2013","journal-title":"Trends Immunol."},{"issue":"4","key":"10.1016\/j.cyto.2018.08.032_b0075","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/nri3174","article-title":"Targeting natural killer cells and natural killer T cells in cancer","volume":"12","author":"Vivier","year":"2012","journal-title":"Nat. Rev. Immunol."},{"issue":"10\u201311","key":"10.1016\/j.cyto.2018.08.032_b0080","first-page":"529","article-title":"KRN7000, a novel immunomodulator, and its antitumor activities","volume":"7","author":"Kobayashi","year":"1995","journal-title":"Oncol. Res."},{"issue":"1","key":"10.1016\/j.cyto.2018.08.032_b0085","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/nri2451","article-title":"Harnessing invariant NKT cells in vaccination strategies","volume":"9","author":"Cerundolo","year":"2009","journal-title":"Nat. Rev. Immunol."},{"issue":"2","key":"10.1016\/j.cyto.2018.08.032_b0090","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.bcp.2014.08.017","article-title":"Harnessing the antibacterial and immunological properties of mucosal-associated invariant T cells in the development of novel oral vaccines against enteric infections","volume":"92","author":"Abautret-Daly","year":"2014","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.cyto.2018.08.032_b0095","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.yjmcc.2013.06.004","article-title":"Activation of invariant natural killer T cells by alpha-galactosylceramide ameliorates myocardial ischemia\/reperfusion injury in mice","volume":"62","author":"Homma","year":"2013","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"2","key":"10.1016\/j.cyto.2018.08.032_b0100","doi-asserted-by":"crossref","first-page":"G249","DOI":"10.1152\/ajpgi.00041.2009","article-title":"Preactivation of NKT cells with alpha-GalCer protects against hepatic ischemia-reperfusion injury in mouse by a mechanism involving IL-13 and adenosine A2A receptor","volume":"297","author":"Cao","year":"2009","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"issue":"2","key":"10.1016\/j.cyto.2018.08.032_b0105","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.jamcollsurg.2007.03.012","article-title":"Adrenomedullin and adrenomedullin binding protein-1 prevent acute lung injury after gut ischemia-reperfusion","volume":"205","author":"Dwivedi","year":"2007","journal-title":"J. Am. Coll. Surg."},{"issue":"4","key":"10.1016\/j.cyto.2018.08.032_b0110","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1001\/archsurg.1970.01340280030009","article-title":"Intestinal mucosal lesion in low-flow states. I. A morphological, hemodynamic, and metabolic reappraisal","volume":"101","author":"Chiu","year":"1970","journal-title":"Arch. Surg."},{"issue":"7","key":"10.1016\/j.cyto.2018.08.032_b0115","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1038\/labinvest.2012.55","article-title":"Kinetic effects of carbon monoxide inhalation on tissue protection in ventilator-induced lung injury","volume":"92","author":"Faller","year":"2012","journal-title":"Lab. Invest."},{"issue":"1","key":"10.1016\/j.cyto.2018.08.032_b0120","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/01.sla.0000167849.10599.30","article-title":"Mechanisms responsible for vascular hyporesponsiveness to adrenomedullin after hemorrhage: the central role of adrenomedullin binding protein-1","volume":"242","author":"Wu","year":"2005","journal-title":"Ann. Surg."},{"issue":"5","key":"10.1016\/j.cyto.2018.08.032_b0125","first-page":"1728","article-title":"IFN-gamma-mediated inhibition of tumor angiogenesis by natural killer T-cell ligand, alpha-galactosylceramide","volume":"100","author":"Hayakawa","year":"2002","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.cyto.2018.08.032_b0130","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1111\/bjh.13092","article-title":"Stimulation of invariant natural killer T cells by alpha-Galactosylceramide activates the JAK-STAT pathway in endothelial cells and reduces angiogenesis in the 5T33 multiple myeloma model","volume":"167","author":"Nur","year":"2014","journal-title":"Br. J. Haematol."},{"issue":"6","key":"10.1016\/j.cyto.2018.08.032_b0135","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.imbio.2014.12.019","article-title":"NKT cell activation by local alpha-galactosylceramide administration decreases susceptibility to HSV-2 infection","volume":"220","author":"Iversen","year":"2015","journal-title":"Immunobiology"},{"issue":"1","key":"10.1016\/j.cyto.2018.08.032_b0140","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/nri1531","article-title":"alpha-Galactosylceramide therapy for autoimmune diseases: prospects and obstacles","volume":"5","author":"Van Kaer","year":"2005","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.cyto.2018.08.032_b0145","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1165\/rcmb.2004-0010OC","article-title":"alpha-Galactosylceramide, a ligand of natural killer T cells, inhibits allergic airway inflammation","volume":"33","author":"Matsuda","year":"2005","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"1","key":"10.1016\/j.cyto.2018.08.032_b0150","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1574-695X.2012.00939.x","article-title":"Protective role of alpha-galactosylceramide-stimulated natural killer T cells in genital tract infection with Chlamydia muridarum","volume":"65","author":"Wang","year":"2012","journal-title":"FEMS Immunol. Med. Microbiol."},{"issue":"1","key":"10.1016\/j.cyto.2018.08.032_b0155","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1053\/gast.2000.9114","article-title":"Activation of natural killer T cells by alpha-galactosylceramide in the presence of CD1d provides protection against colitis in mice","volume":"119","author":"Saubermann","year":"2000","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.cyto.2018.08.032_b0160","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1097\/01.ju.0000158122.16046.68","article-title":"Activation of natural killer T cells by alpha-galactosylceramide mediates clearance of bacteria in murine urinary tract infection","volume":"173","author":"Minagawa","year":"2005","journal-title":"J. Urol."},{"issue":"Suppl 1","key":"10.1016\/j.cyto.2018.08.032_b0165","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1016\/S1166-7087(14)70058-2","article-title":"Innate and adaptive immune responses subsequent to ischemia-reperfusion injury in the kidney","volume":"24","author":"Denecke","year":"2014","journal-title":"Prog. Urol."},{"key":"10.1016\/j.cyto.2018.08.032_b0170","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/532717","article-title":"NK and NKT cell depletion alters the outcome of experimental pneumococcal pneumonia: relationship with regulation of interferon-gamma production","volume":"2015","author":"Christaki","year":"2015","journal-title":"J. Immunol. Res."},{"issue":"3","key":"10.1016\/j.cyto.2018.08.032_b0175","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1189\/jlb.0506298","article-title":"Pivotal advance: alpha-galactosylceramide induces protection against lipopolysaccharide-induced shock","volume":"81","author":"Sireci","year":"2007","journal-title":"J. Leukoc. Biol."},{"issue":"3","key":"10.1016\/j.cyto.2018.08.032_b0180","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1038\/mi.2014.101","article-title":"Conditional IL-4\/IL-13-deficient mice reveal a critical role of innate immune cells for protective immunity against gastrointestinal helminths","volume":"8","author":"Oeser","year":"2015","journal-title":"Mucosal. Immunol."},{"issue":"5","key":"10.1016\/j.cyto.2018.08.032_b0185","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1084\/jem.20102149","article-title":"Memory\/effector (CD45RB(lo)) CD4 T cells are controlled directly by IL-10 and cause IL-22-dependent intestinal pathology","volume":"208","author":"Kamanaka","year":"2011","journal-title":"J. Exp. Med."},{"issue":"1","key":"10.1016\/j.cyto.2018.08.032_b0190","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1136\/gut.2003.023150","article-title":"Recombinant human interleukin 10 suppresses gliadin dependent T cell activation in ex vivo cultured coeliac intestinal mucosa","volume":"54","author":"Salvati","year":"2005","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.cyto.2018.08.032_b0195","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/0092-8674(93)80068-P","article-title":"Interleukin-10-deficient mice develop chronic enterocolitis","volume":"75","author":"Kuhn","year":"1993","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.cyto.2018.08.032_b0200","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1089\/jir.2008.0057","article-title":"Interferon-gamma regulation of intestinal epithelial permeability","volume":"29","author":"Beaurepaire","year":"2009","journal-title":"J. Interferon Cytokine Res."},{"issue":"5","key":"10.1016\/j.cyto.2018.08.032_b0205","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1038\/sj.bjp.0704336","article-title":"Effects of inhibition of PDE4 and TNF-alpha on local and remote injuries following ischaemia and reperfusion injury","volume":"134","author":"Souza","year":"2001","journal-title":"Br. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.cyto.2018.08.032_b0210","doi-asserted-by":"crossref","first-page":"593","DOI":"10.3892\/ijmm.2012.1044","article-title":"Enhancing apoptotic cell clearance mitigates bacterial translocation and promotes tissue repair after gut ischemia-reperfusion injury","volume":"30","author":"Wu","year":"2012","journal-title":"Int. J. Mol. Med."},{"issue":"3","key":"10.1016\/j.cyto.2018.08.032_b0215","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1164\/rccm.200804-625OC","article-title":"Milk fat globule epidermal growth factor 8 attenuates acute lung injury in mice after intestinal ischemia and reperfusion","volume":"181","author":"Cui","year":"2010","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"6","key":"10.1016\/j.cyto.2018.08.032_b0220","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1007\/s00134-011-2172-x","article-title":"Acute intestinal failure in critically ill patients: is plasma citrulline the right marker?","volume":"37","author":"Piton","year":"2011","journal-title":"Intensive Care Med."},{"issue":"3","key":"10.1016\/j.cyto.2018.08.032_b0225","doi-asserted-by":"crossref","first-page":"204","DOI":"10.4037\/ajcc1997.6.3.204","article-title":"Gut dysfunction in critically ill patients: a review of the literature","volume":"6","author":"Stechmiller","year":"1997","journal-title":"Am. J. Crit. Care"},{"issue":"4","key":"10.1016\/j.cyto.2018.08.032_b0230","doi-asserted-by":"crossref","DOI":"10.1097\/SLA.0000000000000916","article-title":"A novel approach to maintain gut mucosal integrity using an oral enzyme supplement","volume":"260","author":"Hamarneh","year":"2014","journal-title":"Ann. Surg."}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466618303673?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466618303673?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T20:50:56Z","timestamp":1760907056000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466618303673"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":46,"alternative-id":["S1043466618303673"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2018.08.032","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Natural killer T cell ligand alpha-galactosylceramide protects against gut ischemia reperfusion-induced organ injury in mice","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2018.08.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}